Resistance of infection by Plasmodium vivax to chloroquine in Bolivia

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Añez, Arletta ^a,b   Moscoso, Manuel ^c   Laguna, Ángel ^c   Garnica, Cecilia ^c   Melgar, Viviana ^c   Cuba, Mauren ^d   Gutierrez, Sonia ^e   Ascaso, Carlos ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Programa de Malaria   (Bolivia)

^c Instituto Nacional de Laboratorios de Salud Bolivia   (Bolivia)

^d Centro de Salud Rene Salazar   (Bolivia)

^e Gerencia de Salud Riberalta Beni   (Bolivia)

Author keywords

Antimalarial drugs; Bolivia; Chloroquine; Plasmodium vivax

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BOLIVIA; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING; DRUG EFFECTS; DRUG RESISTANCE; MALARIA, VIVAX; MIDDLE AGED; PARASITOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; BOLIVIA; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; TREATMENT FAILURE; YOUNG ADULT;

EID: 84948671907     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0774-4     Document Type: Article

References (24)

1. WHO (2012) World Malaria report 2012. World Health Organization, Geneva
2. PAHO (2011) Directrices para el tratamiento de la malaria. 2da ed. Organización Panamericana de la Salud, Washington DC
3. Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK, Rieckmann KH (1992) Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86:121-122
4. Sumawinata IW, Bernadeta, Leksana B, Sutamihardja A, Purnomo, Subianto B et al (2003) Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg 68:416-420
5. Baird JK, Basri H, Subianto B, Fryauff DJ, Mcelroy PD, Leksana B et al (1995) Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 171:1678-1682
6. Phillips EJ, Keystone JS, Kain KC (1996) Failure of combined chloroquine and high dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 23:1171-1173
7. Ruebush TK, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR et al (2003) Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg 69:548-552
8. Marques MM, Costa MR, Santana Filho FS, Vieira JL, Nascimento MT, Brasil LW et al (2013) Plasmodium vivax chloroquine resistance and anemia in the western Brazilian Amazon. Antimicrob Agents Chemother 58:342-347
9. Martínez E, Yucra WO, Castro V, Figueroa RV, De la Cruz L, Téllez C et al (2009) Evaluación de la eficacia de la cloroquina para el tratamiento de la malaria por Plasmodium vivax en Yacuiba, Tarija, Bolivia. Cuad Hosp Clín 54:27-33
10. Añez A, Navarro-Costa D, Yucra O, Garnica C, Melgar V, Moscoso M et al (2012) Respuesta terapéutica de Plasmodium vivax a la cloroquina, en Riberalta, Guayaramerín y Yacuiba, Bolivia. Biomédica 32:527-535
11. MSyD (2011) Situación Actual de la malaria en Bolivia. Parte Epidemiológico 2011, Ministerio de Salud y Deportes, La Paz
12. WHO (2009) Methods for surveillance of antimalarial drug efficacy. World Health Organization, Geneva
13. MSyD (2010) Guía practica de diagnóstico de la malaria. Serie Documentos Técnicos Normativos 154, Ministerio de Salud y Deportes, La Paz
14. Baird JK (2005) Effectiveness of antimalarial drugs. N Engl J Med 352:1565-1577
15. Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi et al (1997) Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg 56:621-626
16. Baird JK (2004) Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 11:4075-4083
17. Murphy GS, Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL et al (1993) Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341:96-100
18. WHO (2011) Methods and techniques for assessing exposure to antimalarial drugs in clinical field studies, World Health Organization, Geneva
19. De Santana Filho FS, Lima-Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL et al (2007) Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13:1125-1129
20. Gonçalves LA, Cravo P, Ferreira MU (2014) Emerging Plasmodium vivax resistance to chloroquine in South America. An overview. Mem Inst Oswaldo Cruz 109:534-539
21. Sinclair D, Gogtay N, Brand F, Olliaro P (2011) Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Cochrane Database Syst Rev 6:CD008492
22. Mezzacappa MA, Facchini FP, Pinto AC, Cassone AE, Souza DS, Bezerra MA et al (2010) Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants. J Perinatology 30:819-826
23. Wilairatana P, Silachamroon U, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V et al (1999) Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg 61:973-977
24. Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA et al (2013) Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother 57:1128-1135